Drug Deliveries - Rituximab 2023

CzechTenders notice for Drug Deliveries - Rituximab 2023. The reference ID of the tender is 80482987 and it is closing on 17 Apr 2023.

100% Secure Payments

Tender Details

  • Country: Czech Republic
  • Summary: Drug Deliveries - Rituximab 2023
  • CZT Ref No: 80482987
  • Deadline: 17 Apr 2023
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 42850000.00
  • Notice Type: Tender
  • Document Ref. No.: 160217-2023
  • Purchaser's Detail :
  • Purchaser : INSTITUTE OF RHEUMATOLOGY
    Address : Na Slupi 450/4
    Town : Prague
    NUTS-Code : CZ01 - Praha
    Postal Code : 12800
    Contact Point : JUDr. Mgr. Barbora Lindova
    Phone : 420 234075365
    Email :lindova@revma.cz
    URL :http://www.revma.cz

  • Description :
  • The subject of performance is continuous supplies according to Annex No. 1 of the Purchase Agreement_Price offer, in the scope and in accordance with the terms of reference, the supplies of the medicinal product Rixathon - L01XC02
    Doc Title: Antineoplastic and immunomodulating agents
    Contract Type: Supplies
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
CzechTenders Features

CzechTenders Features

Fresh and verified Tenders from Czech. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Czech in your email inbox.

  Chat with us